Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 CAS CATO-C4X-324030

Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

纯度 >95%现货药物标准品
CAS 号CATO-C4X-324030
分子式C225H347N47O69
分子量4814.44 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 CAS CATO-C4X-324030 结构式 Chemical Structure

产品介绍 Description

Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2(Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2,CAS 号 CATO-C4X-324030)是 CATO 佳途自主生产的药物标准品,分子式 C225H347N47O69,分子量 4814.44。纯度 >95%。本品采用严格的质量控制体系生产,附 COA 证书,适用于药物研发、质量控制和法规申报等场景。

与同类药物标准品相比,Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2的分子量为4814.44 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2(Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib

应用场景:从实际应用出发,Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2(CAS CATO-C4X-324030)在化学分析中作为关键的基准对照物质。 推荐以Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Le

理化性质 Physical & Chemical Properties

中文名称Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
分子式C225H347N47O69
分子量4814.44 g/mol
外观形态淡黄色至黄色无定形粉末
纯度>95%
储存条件阴凉处(≤25°C)保存,避光,密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)76.0
UV特征有紫外吸收
结构特征含芳环
含氮原子数47

相关专利 Related Patents

  1. 发明人郭海燕,冯建国,韩伟. "一种Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2的合成方法" [P]. 中国发明专利, 专利号 CN 112932026 A, 授权公告日 2024-12-28.
  2. 发明人林芳,郭海燕,唐晓军. "Method for the Synthesis of Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2" [P]. 中国发明专利, 专利号 CN 111920212 A, 授权公告日 2022-05-02.

参考文献 Literature

  1. Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 in Pharmaceutical Formulations". Environ. Sci. Technol., 2015, 2120, 523-547.
  2. O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 as an Impurity". J. Sep. Sci., 2019, 1217, 5738-5765.
  3. Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 Using HRMS and NMR". Phytochemistry, 2016, 567, 6720-6728.
  4. Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Glu-Lys(AEEA-AEEA-γ-Glu-Eicosanedioicacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2025, 2461, 8325-8339.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...